Treatment of patients with schizophrenia and comorbid substance use disorders

被引：0

作者：

Dilbaz, Nesrin ^{[2
]}

Darcin, Asli Enez ^{[1
]}

机构：

[1] Hastanesi Psikiyatri Klin, Kayseri, Turkey

[2] Hastanesi 2 Psikiyatri Klin, Ankara, Turkey

来源：

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2011年 / 21卷 / 01期

关键词：

Schizophrenia; alcohol; substance; comorbidity; treatment; INDUCED PSYCHOTIC DISORDER; PLACEBO-CONTROLLED TRIAL; CANNABIS USE; SMOKING-CESSATION; DRUG-ABUSE; ANTIPSYCHOTIC MEDICATIONS; ATYPICAL ANTIPSYCHOTICS; RESISTANT SCHIZOPHRENIA; OLANZAPINE TREATMENT; COCAINE DEPENDENCE;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Almost half of schizophrenic patients also present with a lifetime history of substance use disorders, a rate that is much higher than that seen in the general population. Although this comorbidity is associated with poorer clinical outcomes, treatments of these patients rarely target substance use. This paper provides a review of the literature on treatment of substance use disorders in schizophrenic patients.

引用

页码：80 / 90

页数：11

共 50 条

[1] Treatment for Outpatients with Comorbid Schizophrenia and Substance Use Disorders: A Review
De Witte, Nele A. J.
Crunelle, Cleo L.
Sabbe, Bernard
Moggi, Franz
Dom, Geert
[J]. EUROPEAN ADDICTION RESEARCH, 2014, 20 (03) : 105 - 114
[2] Treating comorbid substance use disorders in schizophrenia
Lubman, Dan I.
King, Joel A.
Castle, David J.
[J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2010, 22 (02) : 191 - 201
[3] Morbidity and mortality in schizophrenia with comorbid substance use disorders
Lahteenvuo, Markku
Batalla, Albert
Luykx, Jurjen J.
Mittendorfer-Rutz, Ellenor
Tanskanen, Antti
Tiihonen, Jari
Taipale, Heidi
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 2021, 144 (01) : 42 - 49
[4] Treatment compliance in patients with comorbid psychiatric and substance use disorders
Herbeck, DM
Fitek, DJ
Svikis, DS
Montoya, ID
Marcus, SC
West, JC
[J]. AMERICAN JOURNAL ON ADDICTIONS, 2005, 14 (03): : 195 - 207
[5] Treatment of Schizophrenia and Comorbid Substance Use Disorder
Green, Alan, I
Salomon, Melinda S.
Brenner, Mark J.
Rawlins, Kimberly
[J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (02) : 129 - 139
[6] Comorbid substance use disorders in schizophrenia: A latent class approach
Kerner, Befit
[J]. PSYCHIATRY RESEARCH, 2015, 225 (03) : 395 - 401
[7] Diagnostic and Treatment Considerations: Bipolar Patients with Comorbid Substance Use Disorders
Salloum, Ihsan M.
Williams, Lauren
Douaihy, Antoine
[J]. PSYCHIATRIC ANNALS, 2008, 38 (11) : 716 - 723
[8] Pharmacological treatment of schizophrenia with comorbid substance use disorder
Azorin, Jean-Michel
Simon, Nicolas
Adida, Marc
Belzeaux, Raoul
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (02) : 231 - 253
[9] Treatment of substance use disorders in schizophrenia
Bennett, Melanie E.
Bradshaw, Kristen R.
Catalano, Lauren T.
[J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2017, 43 (04): : 377 - 390
[10] Integrated treatment of comorbid depression and substance use disorders
Charney, DA
Paraherakis, AM
Gill, KJ
[J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (09) : 672 - 677

← 1 2 3 4 5 →